Head and Neck Cancer

HEAD AND NECK CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening

The test can accurately detect cancer and predict where it is located, according to researchers.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials

A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Closing the Gap Between Cancer Patients and Researchers: A Patient Advocate’s Perspective on GRASP

Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates

GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Epigenetic Clock May Reveal Biological Aging After Cancer Treatment and Allow for Objective Measurement of Fatigue

Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.

HEAD AND NECK CANCER NEWS

Patient Perception of Outcomes Associated With Psychosocial Function After Reconstruction for Head and Neck Cancer

August 2, 2021

Lobaplatin-Based Regimen May Be ‘Promising’ Alternative for Nasopharyngeal Carcinoma

July 30, 2021

covid vaccine vials

Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment

July 15, 2021

Racial minorities are poorly represented in genomic research databases, raising important questions

African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care

June 9, 2021

Sometimes the distinctions between cancer treatment groups are a little blurry. Here’s a guide to their definitions and origins.

Camrelizumab Plus Chemo Could Be New Standard for Recurrent, Metastatic Nasopharyngeal Carcinoma

June 7, 2021

Next post in Head and Neck Cancer

Lobaplatin-Based Regimen May Be ‘Promising’ Alternative for Nasopharyngeal Carcinoma